# Safety, Tolerability and Pharmacokinetic Profile of an Infusion of Cilastatin in Healthy Volunteers.

> **NCT03595189** · PHASE1 · COMPLETED · sponsor: **Spherium Biomed** · enrollment: 23 (actual)

## Conditions studied

- Dose Finding Study

## Interventions

- **DRUG:** Cilastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03595189
- **Lead sponsor:** Spherium Biomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-19
- **Primary completion:** 2018-08-09
- **Final completion:** 2018-08-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03595189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03595189, "Safety, Tolerability and Pharmacokinetic Profile of an Infusion of Cilastatin in Healthy Volunteers.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03595189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*